Перегляд за Автор "Gusachenko, I."
Зараз показуємо 1 - 4 з 4
Результатів на сторінці
Налаштування сортування
Документ L-arginine is an effective medication for prevention of endothelial dysfunction, a predictor of anthracycline cardiotoxicity in patients with acute leukemia(ООО «МОРИОН», 2017-12) Skrypnyk, I.; Maslova, G.; Lymanets, T.; Gusachenko, I.; Скрипник, Ігор Миколайович; Маслова, Ганна Сергіївна; Лиманець, Тетяна ВолодимирівнаДокумент Quality of life evaluation in acute leukemia patients receiving induction chemotherapy(European society for medical oncology, 2018-10) Lymanets, T. V.; Skrypnyk, I. M.; Maslova, G. S.; Gusachenko, I.; Лиманець, Тетяна Володимирівна; Скрипник, Ігор Миколайович; Маслова, Ганна СергіївнаBackground: Over the past decades, special attention has been paid to study of quality of life (QoL) indicators in hematological patients receiving chemotherapy (CT). Nowadays QoL is conceptually viewed as an important complement to traditional objective evaluation measures. Aim. To assess QoL in patients with acute leukemia (AL) depending on the presence of concomitant ischemic heart disease (1HD) during the induction CT. Methods: Our study involved 83 patients with newly diagnosed AL, of which 19 were lymphoblastic, 64-myeloid leukemia, aged 16-72,43 (51.8%) men, 40 (48.2%) women, according to ECOG l-II. Patients received standard induction CT. According to concomitant IFID patients were divided into groups: I (n — 47) - AL without cardio logical diseases; II (n = 36) - AL with concomitant IHD. Patients were evaluated using SF-36 questionnaire to calculate physical and mental health components before treatment and after 2 induction courses of CT reaching remission.Документ Quality of life in acute leukemia patients with comorbid ischemic heart disease(2018-06-14) Lymanets, T.; Skrypnyk, I.; Maslova, G.; Gusachenko, I.; Скрипник, Ігор Миколайович; Лиманець, Тетяна Володимирівна; Маслова, Ганна СергіївнаДокумент Risk assessment of anthracycline cardiotoxicity in patients with acute leukemia and concomitant ischemic heart disease(Hemasphere journal, 2019) Lymanets, T. V.; Skrypnyk, I. M.; Maslova, H. S.; Gusachenko, I.; Лиманець, Тетяна Володимирівна; Скрипник, Ігор Миколайович; Маслова, Ганна СергіївнаBackground: Great attention has recently been focused on the problem of chemotherapy (CT) complications in patients with acute leukemia (AL). Notable among them is the anthracycline cardiotoxicity (AC), the development of which greatly inhibits the carrying out of CT in full doses, which significantly reduces the patients’ chances for life. The presence of concomitant ischemic heart disease (IHD) potentiates the formation of AC, increases the risk of myocardial injury development. Aims: To assess the risk factors of AC development on low cumulative doses of anthracycline antibiotics (AA) and to increase the efficacy of AC prevention in patients with AI, taking into account concomitant IHD. Methods: The study involved 147 patients with newly diagnosed AL, 72 (49%) males and 75 (51%) females, mean age 54.7 ± 9.3 years, ECOG I-II. All patients were treated in hematology department of Poltava Regional Clinical Hospital n.a.M.V.Sklifosovsky. Depending on the IHD presence, the patients were divided into two groups: I (n = 81)-AL pts without concomitant cardiovascular diseases; II (n = 66)-AL pts with IHD. Due to ongoing AC prevention with L-arginine patients of both groups were further subdivided: IA (n = 47) and IIA (n = 36)—pts receiving CT; IB (n = 34) and IIB (n = 30)-pts, who received CT with prophylaxis of AC with L-arginine. The study was approved by the local ethical committee and all patients and all patients signed the inform consent before they were included. The examination was carried out twice: at baseline and after induction CT, when remission was achieved and AA low cumulative doses <200 mg/m2 were reached. The cardiotoxic effect of AA was evaluated by echocardiography and ITolter ECG monitoring and considered to be according to CTCAE 4.03 as reduction of left ventricular ejection fraction (l.VF.F) more than 10% of baseline and QTc prolongation exceeded 450ms. The episodes of “silent ischemia” were assessed on the basis of ST segment depression by 1 mm or more in the absence of typical pain syndrome.